CompanyABEONasdaqCleveland, OH

Abeona Therapeutics, Inc

Abeona Therapeutics develops cell and gene therapies for serious diseases.

SEC EDGAR ClinicalTrials.gov investors.abeonatherapeutics.com

8-KSep 15Latest SEC filing, period to Sep 15

Aug 13Latest story

August 2026

Abeona reports second-quarter ZEVASKYN growth, expanded treatment center network

Aug 13Quarterly updateAbeona Therapeutics, Inc

July 2026

Abeona Therapeutics, Inc updates registry record NCT07717736: not yet recruiting

Jul 21Trial updateAbeona Therapeutics, IncRecord notice

Abeona registers long-term safety registry for ZEVASKYN gene therapy in RDEB

Jul 14Trial updateAbeona Therapeutics, Inc pz-cel